BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 19201736)

  • 1. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
    Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
    Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
    Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ.
    Tang P; Wang X; Schiffhauer L; Wang J; Bourne P; Yang Q; Quinn A; Hajdu S
    Ann Clin Lab Sci; 2006; 36(2):137-43. PubMed ID: 16682508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paget's disease of the nipple in a population based cohort.
    Dalberg K; Hellborg H; Wärnberg F
    Breast Cancer Res Treat; 2008 Sep; 111(2):313-9. PubMed ID: 17952590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases.
    Liegl B; Leibl S; Gogg-Kamerer M; Tessaro B; Horn LC; Moinfar F
    Histopathology; 2007 Mar; 50(4):439-47. PubMed ID: 17448019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acinar pattern of mammary Paget's disease: a case report.
    Barnes PJ; Dumont RJ; Higgins HG
    Breast J; 2007; 13(5):520-6. PubMed ID: 17760678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
    Hanley K; Wang J; Bourne P; Yang Q; Gao AC; Lyman G; Tang P
    Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
    Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.
    van der Groep P; van Diest PJ; Menko FH; Bart J; de Vries EG; van der Wall E
    J Clin Pathol; 2009 Oct; 62(10):926-30. PubMed ID: 19541683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
    Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of Paget's disease of the breast: report of 33 cases].
    Sun Q; Zhou YD; Huang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):93-5. PubMed ID: 12905618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ
    Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paget's disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis.
    Lohsiriwat V; Martella S; Rietjens M; Botteri E; Rotmensz N; Mastropasqua MG; Garusi C; De Lorenzi F; Manconi A; Sommario M; Barbieri B; Cassilha M; Minotti I; Petit JY
    Ann Surg Oncol; 2012 Jun; 19(6):1850-5. PubMed ID: 22322949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a basal-like subtype of breast ductal carcinoma in situ.
    Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
    Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular classifications of breast carcinoma with similar terminology and different definitions: are they the same?
    Tang P; Wang J; Bourne P
    Hum Pathol; 2008 Apr; 39(4):506-13. PubMed ID: 18289638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pagetoid dyskeratosis of the nipple epidermis: an incidental finding mimicking Paget's disease of the nipple.
    Garijo MF; Val D; Val-Bernal JF
    APMIS; 2008 Feb; 116(2):139-46. PubMed ID: 18321365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paget's disease of the breast.
    Sakorafas GH; Blanchard K; Sarr MG; Farley DR
    Cancer Treat Rev; 2001 Feb; 27(1):9-18. PubMed ID: 11237774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.